Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Tissues
  • Tools
  • SNPs by tissue
  • CGAP Data
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Library List

Libraries for cluster Mm.30438

[Full Text]
Displaying 1 thru 22 of 22 items
TitleTissueHistologyTypeProtocolKeywords
RIKEN full-length enriched, 15 days embryo headembryonic tissuenormalbulkuncharacterized treatmentfetus, normal, micro-bulk, full-length enriched, EST, mixed pool by gender, C57BL/6J, embryonic head
RIKEN full-length enriched, 16 days embryo headembryonic tissuenormalbulkuncharacterized treatmentfetus, normal, micro-bulk, full-length enriched, EST, mixed pool by gender, C57BL/6J, embryonic head
Mouse RPE/choroid, unamplified: mi/mjeyenormalbulkuncharacterized treatmentnormal, bulk, adult, choroid, pigmented epithelium, EST, male, plasmid vector, C57BL/6J
NIH_BMAP_GW0eyenormalbulkuncharacterized treatmentfetus, eye, normal, BMAP, bulk, EST, MGC, size fractionated, plasmid vector, oligo-dT primed, C57BL/6
NIH_BMAP_HA0eyenormalbulknon-normalizedfetus, eye, normal, non-normalized, BMAP, bulk, EST, MGC, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6
NIH_BMAP_HB0eyenormalbulknon-normalizedfetus, eye, normal, non-normalized, BMAP, bulk, EST, MGC, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6
NIH_BMAP_HD0eyenormalbulknon-normalizedfetus, eye, normal, non-normalized, BMAP, bulk, EST, MGC, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6
NIH_BMAP_HP0eyenormalbulkuncharacterized treatmentfetus, eye, normal, BMAP, bulk, EST, MGC, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6
NIH_BMAP_HU0eyenormalbulkuncharacterized treatmenteye, normal, BMAP, bulk, juvenile, neonate, EST, MGC, mixed developmental stages, size fractionated, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6
NIH_BMAP_IB0eyenormalbulkuncharacterized treatmenteye, normal, BMAP, bulk, juvenile, neonate, MGC, size fractionated, plasmid vector, directionally cloned, oligo-dT primed, C57BL/6, EST
No3 mouse (cataract/retinal degeneration) whole eye, unamplified: ob/oceyeuncharacterized histologyuncharacterized preparationuncharacterized treatmenteye, adult, EST, plasmid vector, directionally cloned, cataract
RIKEN full-length enriched, 0 day neonate eyeballeyenormalbulkuncharacterized treatmenteye, normal, bulk, full-length enriched, neonate, EST
RIKEN full-length enriched, 12 days embryo eyeballeyenormalbulkuncharacterized treatmentfetus, eye, normal, micro-bulk, EST
mouse eyeball cDNA Libraryeyenormaluncharacterized preparationuncharacterized treatmenteye, normal, adult, EST, plasmid vector
Sugano mouse kidney mkiakidneynormalbulkuncharacterized treatmentkidney, normal, bulk, adult, EST, female, size fractionated, phagemid, oligo-dT primed, C57/BL
RIKEN full-length enriched mouse cDNA library, C57BL/6J B16 F10Y cellsskincancercell lineuncharacterized treatmentskin, melanoma, cell line, EST, unknown developmental stage, C57BL/6J
RIKEN full-length enriched, 10 day neonate skinskinnormalbulkmultiple treatmentskin, normal, bulk, normalized, subtracted, juvenile, full-length enriched, EST, C57BL/6J
RIKEN full-length enriched, 6 days neonate skinskinnormalbulkmultiple treatmentskin, normal, bulk, normalized, subtracted, juvenile, full-length enriched, EST
RIKEN full-length enriched, B16 F10Y cellsskincancercell lineuncharacterized treatmentskin, melanoma, cell line, full-length enriched, EST, unknown developmental stage, C57BL/6J
RIKEN full-length enriched, RCB-1283 B16 melanoma cDNAskincancercell lineuncharacterized treatmentskin, melanoma, cell line, full-length enriched, EST, unknown developmental stage, C57BL/6
RIKEN full-length enriched, melanocyteskinnormalbulkuncharacterized treatmentskin, normal, melanocyte, bulk, full-length enriched, EST, unknown developmental stage, C57BL/6J
RIKEN full-length enriched, pooled cell lines, RCB-0544,etc.uncharacterized tissueuncharacterized histologycell lineuncharacterized treatmentcell line, full-length enriched, mixed (normal and tumor), EST, mixed tissue, mixed developmental stages, mixed pool by gender